Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Alaunos Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −2 vs. Q2 2025
- Shares held
- 65.4K
- −5.63K (−7.9%) vs. Q2 2025
- Total value
- $158.3K
- −$186.3K (−54.1%) vs. Q2 2025
- New holders
- 4
- 3 more added
- Sold out
- 6
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $204.4K |
| Q1 2026 | 29 | $360.5K |
| Q4 2025 | 27 | $349.9K |
| Q3 2025 | 26 | $158.3K |
| Q2 2025 | 28 | $344.6K |
| Q1 2025 | 29 | $103.4K |
| Q4 2024 | 30 | $137.0K |
| Q3 2024 | 29 | $622.8K |
| Q2 2024 | 50 | $1.69M |
| Q1 2024 | 46 | $4.23M |
| Q4 2023 | 86 | $2.96M |
| Q3 2023 | 92 | $7.36M |
| Q2 2023 | 102 | $34.2M |
| Q1 2023 | 110 | $44.7M |
| Q4 2022 | 124 | $50.5M |
| Q3 2022 | 125 | $128.6M |
| Q2 2022 | 125 | $90.7M |
| Q1 2022 | 149 | $65.8M |
| Q4 2021 | 167 | $155.9M |
| Q3 2021 | 163 | $194.1M |
| Q2 2021 | 156 | $297.6M |
| Q1 2021 | 153 | $422.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Alaunos Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 21,353 | $51.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 20,972 | $51.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 15,791 | $38.5K | 0.00% | −155−1.0% | Reduced |
| Morgan Stanley | 1,684 | $4.06K | 0.00% | −114−6.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,633 | $3.94K | 0.00% | +660+67.8% | Added |
| UBS Group AG | 1,533 | $3.69K | 0.00% | −5,282−77.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,165 | $2.81K | 0.00% | +470+67.6% | Added |
| CIBC Private Wealth Group, LLC | 300 | $723 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 183 | $441 | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 135 | $325 | 0.00% | +135 | New |
| Steward Partners Investment Advisory, LLC | 92 | $222 | 0.00% | −1,006−91.6% | Reduced |
| Bank of America Corp | 89 | $214 | 0.00% | +4+4.7% | Added |
| Federation des caisses Desjardins du Quebec | 70 | $169 | 0.00% | −16−18.6% | Reduced |
| Barclays PLC | 50 | $121 | 0.00% | −50−50.0% | Reduced |
| Asset Dedication, LLC | 46 | $111 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 24 | $60 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 24 | $58 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 23 | $55 | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 20 | $48 | 0.00% | +20 | New |
| AdvisorNet Financial, Inc | 19 | $46 | 0.00% | 00.0% | Unchanged |
| Sunbelt Securities, Inc. | 10 | $24 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 6 | $15 | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 1 | $3 | 0.00% | +1 | New |
| Truvestments Capital LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 8 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 198 | $0 | 0.00% | +198 | New |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Investment Management Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |